Add-On Daclizumab Treatment May Be Better In Reducing MS

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Add-On Daclizumab Treatment May Be Better In Reducing MS

Postby thumbsup » Sun Mar 14, 2010 10:38 am

An article published Online First and in the April edition of The Lancet Neurology reports that add-on daclizumab treatment might reduce multiple sclerosis disease activity more than standard interferon beta treatment alone. The article is the work of Dr John W Rose, Neurovirology Research Laboratory, VA Medical Center, Salt Lake City, Utah and University of Utah, USA, and colleagues.

Daclizumab is a humanised monoclonal antibody. It is a genetically engineered antibody with a human structure and specific binding sites. Daclizumab has reduced multiple sclerosis disease activity in earlier non-randomised studies. The authors aimed in this new study to investigate whether daclizumab reduces disease activity in patients with active relapsing multiple sclerosis who are receiving standard interferon beta treatment.
Got it from
User avatar
Getting to Know You...
Posts: 12
Joined: Mon Feb 22, 2010 4:00 pm


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service